Sponsored Links

Featured Links

Other Topics
Sponsored Links



Quote of the Day

"War is a series of catastrophes which result in victory."

Albert Pike

FEATURED
HEALTH
PRODUCTS
 
Guide To Healthier Eating And Weight
 
The Ultimate Collection Of Health Ebooks
 
A Healthy Back In Ten Minutes A Day
 
Complete Guide To Healthy Eating
 
Natural Health Remedies To Help Stress
 




 


Google

 
Featured Diabetes Articles

Insulin
Insulin has two critical roles in the body that we cannot live without, yet it can be the root of many health problems, including diabetes. Insulin carries sugar (glucose), fat and protein into your cells where they are used for energy and the repair of ...

Raising Happy Diabetic Kids Part II Help Yor Child Develop Self-Relience
This is the second article in a series I am writing about how to raise happy diabetic children. You can find the first article titled Help Your Child Develope Self-Confidence in our article archives. Sometimes the phrase "happy diabetic kids" seems to be ...

Symptoms of Diabetes
While it's very easy to test for diabetes symptom , a simple blood glucose test is the determining factor, diabetes may not be easily recognized at first since so many of its symptoms are also common complaints for people who do not have diabetes. For ...





Combination of Thiazide-Type Diuretic and Beta-Blocker may Cause Diabetes
 
Clinical Question: In patients with hypertension is it safe to combine thiazide-type diuretic and beta-blocker?
Bottom Line: Studies suggest that the routine combined use of a thiazide with a beta-blocker should be questioned in the early management of hypertension, particularly in patients who are at increased risk of developing new-onset diabetes. In such patients, the increased risk of developing diabetes may exceed the benefit of blood pressure lowering.
Reference: J Hypertens. 2005 Oct;23(10):1777-1781
Study Design: Retrieve randomized control trials and meta-analysis
Synopsis: Recently published trials addressing the pharmacological management of hypertension have reported an increase in new-onset diabetes mellitus when comparing certain older and newer treatment regimens. Thiazide-type diuretics (thiazides) and beta-blockers have been individually implicated, but these drugs are frequently combined, and the magnitude of risk associated with their combined use has not been quantified. So randomized control trials were retrieved that: (i) featured stepped treatment to manage hypertension; (ii) compared initial treatment using a thiazide or beta-blocker (older drug) with an angiotensin-converting enzyme inhibitor, angiotensin receptor blocker or calcium antagonist (newer drug); (iii) assessed cardiovascular outcomes; (iv) reported new-onset diabetes; and (v) provided at least 1-year follow-up. A meta-analysis of available trials indicated that patients exposed to treatment regimens combining thiazides and beta-blockers are at greater risk of developing diabetes than regimens avoiding this combination of drugs (risk ratio for alternative therapy 0.81, 95% confidence interval 0.77-0.86). Current data cannot inform reliably about the risks associated with individual older drugs because of similar overall exposures in patients starting on newer and older drugs.
About the Author
A Certified Family Physician of the Philippine Academy of Family Physician and continue to complete the requirements for Continuing Medical Education in Family Practice. Also a member of the Philippine Medical Informatics Society, Philippine Occupational Health and Safety Inc., and Pangasinan Medical Society. Faculty Department of Physiology (Medicine) Lyseum- Northwestern University, Dagupan, Pangasinan, Faculty Medical Informatics Lyseu

Diabetes News



New York Daily News

Heart Deaths in Diabetes Plummet
MedPage Today
The death rate from cardiovascular disease in US adults with diabetes fell 40% from 1997 to 2004, CDC and NIH researchers said. Data from the National Health Interview Survey (NHIS) and National Death Index over this period showed that, ...
Death rate drops among Americans with diabetes -CDCReuters
US Sees Drop in Deaths Linked to DiabetesU.S. News & World Report
Study: People are living longer with diabetesNew York Daily News
MarketWatch (press release) -Los Angeles Times
all 489 news articles »

Eli Lilly: Diabetes Drug Meets Cardiovascular Goals
Wall Street Journal
(LLY) said dulaglutide, an investigational treatment for Type 2 diabetes, met a primary endpoint for blood pressure and heart rate effects in a 16-week study. Dulaglutide, which is being studied as a once-weekly treatment for diabetes, was administered ...
Eli Lilly's diabetes drug meets mid-stage trial goalReuters
Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on ...PR Newswire (press release)
Eli Lilly Says Dulaglutide Meets Primary Endpoint - Quick FactsNASDAQ

all 24 news articles »

Diabetes Drug Target Identified
Science Daily (press release)
ScienceDaily (May 21, 2012) — New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic. Patrick Tso, PhD, professor in the UC ...
Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New ...MarketWatch (press release)

all 4 news articles »

Medgadget.com

Diabetes Design Demo Day Semi-Finalist: N4A Diabetes Care Center
Medgadget.com
by Nicholas Genes on May 22, 2012 • 2:26 pm Among all the semi-finalists for Sanofi's Data Design Diabetes Demo Day, we think N4A Diabetes Care Center was the most unexpected and confusing. N4A dates back to 1960′s legislation on aging, and is a loose ...
Beaufort man advances to semifinals in diabetes innovation challengeHilton Head Island Packet

all 6 news articles »

A Sweet Life

Novo Nordisk diabetes drug gets broader approval
CBS News
NEW YORK — Danish drugmaker Novo Nordisk A/S said Tuesday that the Food and Drug Administration granted an additional marketing approval for its diabetes drug Levemir. Novo Nordisk says Levemir is now approved for use in children with type 1 diabetes ...
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ...MarketWatch (press release)
Novo Nordisk Diabetes Drug Approved For ToddlersInvestor's Business Daily
Novo Nordisk's Levemir Insulin Approved for Use in Children as Young as TwoA Sweet Life
Drug Store News
all 13 news articles »